Manipal Health Enterprises Limited

Manipal Health Enterprises Limited's next confirmed earnings release is scheduled for December 2, 2026.

As of March 31, 2026, Manipal Health Enterprises Limited has 1.22B shares outstanding.

As of March 31, 2026, Manipal Health Enterprises Limited maintains a current ratio of 1.22, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 146.19, indicating elevated leverage, while an interest coverage ratio of 2.24 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Manipal Health Enterprises Limited posted a return on equity (ROE) of 9.19, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 6.86 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 2.83, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 7.29, useful for judging operating efficiency across full business cycles. The company generates approximately 4.51M in revenue per employee across its workforce of 24,240.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 23.97 indicates how many times Manipal Health Enterprises Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Manipal Health Enterprises Limited recorded 2.75B in income tax expense. That works out to an effective tax rate of 28.63, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 9.60B, leaving 6.55B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

These figures are as of the close on October 22, 2026.

Over the twelve months ended March 31, 2026, Manipal Health Enterprises Limited generated 109.36B in revenue and converted that into 6.55B in net income, yielding earnings per share of 5.60. EBITDA reached 25.82B, while operating income came in at 19.96B.

As of March 31, 2026, Manipal Health Enterprises Limited holds 28.11B in cash and equivalents against 128.63B in total debt, resulting in a net debt position of 102.54B. Total book value stands at 84.26B, with working capital of 7.47B providing operational flexibility.

Manipal Health Enterprises Limited produced 20.78B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -13.16B in capital expenditures, free cash flow totaled 7.62B - equivalent to 6.23 per share.

Over the twelve months ended March 31, 2026, Manipal Health Enterprises Limited posted a gross margin of 64.90, reflecting its pricing power and cost economics. The operating margin of 18.25 and net profit margin of 5.99 provide insight into operational efficiency.